Related Experiment Video
Updated: Jun 20, 2026

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
Published on: April 22, 2017
Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem
Lukás Cajánek1, Diogo Ribeiro, Isabel Liste
1Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, S-171 77 Stockholm, Sweden.
Abstract:
Embryonic stem cells (ESCs) represent not only a promising source of cells for cell replacement therapy, but also a tool to study the molecular mechanisms underlying cellular signaling and dopaminergic (DA) neuron development. One of the main regulators of DA neuron development is Wnt signaling. Here we used mouse ESCs (mESCs) lacking Wnt1 or the low-density lipoprotein receptor-related protein 6 (LRP6) to decipher the action of Wnt/beta-catenin signaling on DA neuron development in mESCs. We provide evidence that the absence of LRP6 abrogates responsiveness of mESCs to Wnt ligand stimulation. Using two differentiation protocols, we show that the loss of Wnt1 or LRP6 increases neuroectodermal differentiation and the number of mESC-derived DA neurons. These effects were similar to those observed following treatment of mESCs with the Wnt/beta-catenin pathway inhibitor Dickkopf1 (Dkk1). Combined, our results show that decreases in Wnt/beta-catenin signaling enhance neuronal and DA differentiation of mESCs. These findings suggest that: 1) Wnt1 or LRP6 are not strictly required for the DA differentiation of mESCs in vitro, 2) the levels of morphogens and their activity in ESC cultures need to be optimized to improve DA differentiation, and 3) by enhancing the differentiation and number of ESC-derived DA neurons with Dkk1, the application of ESCs for cell replacement therapy in Parkinson's disease may be improved.
Insights
Decreasing Wnt/beta-catenin signaling enhances the development of dopaminergic (DA) neurons from mouse embryonic stem cells (mESCs). This suggests optimizing morphogen levels can improve cell replacement therapy for Parkinson's disease.
Area of Science:
- Stem cell biology
- Developmental neuroscience
- Molecular signaling
Background:
- Embryonic stem cells (ESCs) are valuable for cell replacement therapy and studying neurodevelopment.
- Wnt signaling is a key regulator of dopaminergic (DA) neuron development.
- Understanding Wnt signaling's role in ESC differentiation is crucial for therapeutic applications.
Purpose of the Study:
- To investigate the role of Wnt/beta-catenin signaling in dopaminergic (DA) neuron development from mouse ESCs (mESCs).
- To decipher the specific actions of Wnt1 and low-density lipoprotein receptor-related protein 6 (LRP6) in this process.
- To assess the potential of modulating Wnt signaling for improving ESC-based therapies.
Main Methods:
- Utilized mESCs genetically modified to lack Wnt1 or LRP6.
- Employed two distinct differentiation protocols to generate DA neurons.
- Assessed neuroectodermal differentiation and DA neuron yield.
- Compared results with treatments using the Wnt/beta-catenin inhibitor Dickkopf1 (Dkk1).
Main Results:
- Absence of LRP6 abolished mESC response to Wnt ligands.
- Loss of Wnt1 or LRP6 significantly increased neuroectodermal differentiation.
- Reduced Wnt/beta-catenin signaling, via genetic knockout or Dkk1 treatment, enhanced DA neuron production.
- These findings highlight the inhibitory effect of Wnt signaling on DA differentiation.
Conclusions:
- Wnt1 and LRP6 are not essential for in vitro DA differentiation of mESCs.
- Optimizing morphogen levels and Wnt pathway activity is critical for efficient DA neuron differentiation.
- Modulating Wnt/beta-catenin signaling, for example with Dkk1, holds promise for enhancing ESC-based cell replacement therapies for Parkinson's disease.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...

